Serum selenium and fasting blood glucose: a cross-sectional study in women of different menopause status

Abstract

Abstract Background This cross-sectional study aims to explore whether there exists an interaction between selenium and menopause concerning type 2 diabetes (T2D) prevalence and its related indicators such as fasting blood glucose (FBG) and homeostasis model assessment of insulin resistance (HOMA-IR). Methods 150 women aged 35–60 years old were finally analyzed in this study. Multivariate linear or logistic regression modeling was conducted to explore the association of selenium and the prevalence of T2D besides its related indicators. Subgroup analyses were conducted based on menopause status to assess the potential impact on the relationship. Results In the fully adjusted model, serum selenium was positively associated with FBG (β: 0.03, CI: 0.01–0.05) and the prevalence of T2D (OR: 1.04, CI: 1.00–1.08). After stratifying the data by menopause status, compared with the postmenopausal women group, as the serum selenium concentrations increased, the FBG concentrations were significantly higher in the premenopausal women group (p for interaction = 0.0020). Conclusions The present study found serum selenium was positively associated with FBG and the prevalence of T2D. Furthermore, the relationship between serum selenium and FBG was different in the premenopausal and postmenopausal women. More studies are still needed in the future to verify the relationship as well as to explore the specific mechanisms.

Keywords

• Serum selenium
• Fasting blood glucose
• Menopause
• T2D
• Cross-sectional study